A vaccine that blocks infection with the human papillomavirus has helped to lower cervical cancer rates. Researchers want to ...

HPV is one of the most common infections causing genital warts or cervical cancer in women. Vaccination is the best way to prevent the disease. The vaccine has already been introduced in 140 countries ...

Worldwide, 350,000 women die from cervical cancer, the most common HPV cancer. “I think we can all agree that one dose and two doses of … these fantastic vaccines work really well,” said ...

HPV (human papillomavirus) is a common virus in the UK, and it is estimated that eight out of 10 people will be infected with HPV at some point in their lives. Chris Johnson, Head of the Vaccine ...

SEATTLE — Since its approval by the U.S. Food and Drug Administration in 2006, the HPV vaccine has made considerable strides in preventing cervical and oropharyngeal, or throat cancers.

Manipal Hospital Hebbal, in collaboration with Reach Lives, conducted an HPV vaccination drive for 70 underprivileged girls, offering the vaccine at no cost. Dr Shalini Sharma, Consultant ...

The FDA has approved Teal Health's at-home test for HPV detection, which may help expand access to cervical cancer screening ...

Physicians welcomed the vaccination program expansion, calling it ‘an extremely important step’ to tackle HPV, the most common sexually transmitted infection in the world. The National Program ...

The HPV vaccine can prevent cancers, including cervical cancer. It's recommended for girls between the ages nine and 45. Only about three in 10 eligible girls in Kenya received the human ...

The AACR meeting was full of promising data on the vaccine against cervical cancer, a lung cancer drug and the next generation of KRAS inhibitors.

In fact, it protects reproductive health by preventing HPV-related cancers. Myth 2: The HPV vaccine encourages promiscuity Some critics argue that vaccinating girls against a sexually transmitted ...

HPV is fuelling high cervical cancer rates in sub-Saharan Africa despite the availability of effective vaccines. Yet uptake remains low, driven largely by vaccine hesitancy. In South Africa alone, ...